QuinStreet Form 4 Filed for James R. Simons
A Form 4 for QuinStreet covering Oct. 29 was filed Nov. 2.
Related stories
TETRA Technologies Reports Quarterly Results Through September 30
M impact | EQUITY | Nov 02, 2026, 11:39 PM UTC
Samsung Biologics Signs $324.8 Million Drug Manufacturing Contract
Samsung Biologics signed a drug manufacturing contract worth USD 324.8 million.
M impact | EQUITY | Nov 02, 2026, 11:37 PM UTC
Ero Copper Reports Quarterly Results for Quarter Ended September 30
M impact | EQUITY | Nov 02, 2026, 11:36 PM UTC
PLDT Auditor SGV Resigns Over Independence Concerns
PLDT’s auditor, SyCip Gorres Velayo (SGV), resigned, citing a lack of independence.
M impact | EQUITY | Nov 02, 2026, 11:34 PM UTC
Argentine Stocks Fall for Sixth Straight Session as Country Risk Tops 800
Argentine shares fell for a sixth consecutive session, country risk exceeded 800 points and the central bank did not buy reserves.
M impact | EQUITY | Nov 02, 2026, 11:34 PM UTC
Axsome Therapeutics Shares Hit 52-Week Low as Much as 15%
Axsome shares fell as much as 15% on Monday as investors focused on Auvelity launch pacing in Alzheimer’s disease agitation, despite the company’s strong third-quarter report.
M impact | EQUITY | Nov 02, 2026, 11:32 PM UTC